Global Centre for Person-Centred Value-Based Health Care
Nicola is a founding partner of Millwater Partners, a consultancy focusing on sustainability, and is the lead for health, social policy, and multi-stakeholder engagement.
From 2006 to spring 2019, she served as Secretary General of the European Patients’ Forum (EPF), growing the organisation from 23 to 74 member organisations and creating a vibrant secretariat in Brussels. She was instrumental in establishing EPF as the key interlocutor for the EU Institutions, WHO and OECD on cross-cutting policy issues affecting all patients.
Nicola studied business and human resource management in the UK and France. She has lived in the UK, France, Belgium, and Switzerland, and for the last 8 years in Vienna, Austria.
Matt designs and delivers online learning content, strategic communications, and webinars to help organisations put Value-Based Health Care in practice.
Matt is a content and communications consultant. He has a wide range of experience, including content design, user research, strategic communication, journalism, editing, copywriting and developing online learning. He has led projects across healthcare, education, finance, security, and defence sectors. Past clients include the Cabinet Office (UK), the British Medical Journal (BMJ) and the International Consortium for Health Outcomes Measurement (ICHOM).
Arie is a member of the steering committee on Value-Based Health Care at Erasmus Medical Center, Netherlands.
He works on Value-Based Health Care with the Netherlands Federation of University Medical Centers, the Dutch Ministry of Health and the Netherlands Healthcare Institute. He was the chair of the global ICHOM Working Group developing the Pregnancy and Childbirth Standard Set of outcomes.
Arie is co-founder and co-chairman of the Linnean Initiative (www.linnean.nl), a nationwide multidisciplinary network aiming to accelerate the implementation of Value-Based Health Care in the Netherlands.
Arie holds an MD degree from the Free University in Amsterdam, Netherlands and a PhD degree from the University of Utrecht, Netherlands.
Prior to his current role as CEO of Sprink, between 2018 and 2019, Thomas was the National Clinical Advisor on Value- Based Health Care (VBHC) for the Welsh Government.
Between 2013 and 2018 he worked at the International Consortium for Health Outcomes Measurement (ICHOM). He established the London office in 2014 and subsequently led ICHOM’s work in the EMEA region between 2014 and 2017. In 2017 he took overall responsibility for ICHOM’s day-to-day operations across its London and Boston offices. He also had global responsibility for ICHOM’s strategic partnerships.
Prior to working at ICHOM he practiced as a physician at Oxford University Hospitals (OUH).
He received his BSc and MD from the University of Manchester, UK and MBA from the University of Oxford, UK.
Kemi is a data-driven physician focused on Value-Based Health Care. She is currently the Vice President of Clinical Services of Archway Health, where she works with providers to develop alternative payment models.
She was previously a manager at the International Consortium for Health Outcomes Measurement (ICHOM), where she worked on initiatives aiming to use provider data to drive improvements in patient outcomes.
Kemi received a master’s degree from the Harvard T.H. Chan School of Public Health, USA and a medical degree from the University of Nottingham Medical School, UK
Pat is Chief Executive at Mapat Management Consultants where he provides strategic management consultancy to selected clients.
Pat is also Executive Chairman of Muir PT, which is planning to provide Proton Therapy services on the island of Ireland, Chairman of the Board of the Health Information and Quality Authority (HIQA) and Chairman of the Board of the Irish Medicines Verification Organisation (IMVO).
Pat previously served as CEO at Clinical Research Development Ireland, the clinical and translational research partnership of the universities in Ireland from 2017 to 2019, Deputy Secretary General and Head of Governance and Performance at the Department of Health in Dublin for 15 months, prior to which Pat was Chief Executive of the Health Products Regulatory Authority from 2002 to 2015.
Pat has previously served on a variety of public and private sector boards including the European Medicines Agency (EMA), where he served as Chairman from 2007 to 2011, the Food Safety Authority of Ireland, the National Patient Safety Advisory Group and was Vice Chair of the International Coalition of Medicines Regulatory Authorities. Pat was appointed Adjunct Professor at UCD in 2017.
Matt is a project management professional with a portfolio in various NHS organisations.
He has led the creation of a number of Standard Sets of outcomes for the International Consortium for Health Outcomes Measurement (ICHOM).
Matt studied Sports Science at undergraduate level before going on to gain a master’s degree in Public Health, both at the University of Birmingham, UK.
Andrea was previously the Programme Manager of the Diabetes Quality Team at the Royal College of Paediatrics and Child Health (RCPCH) in London, UK.
Before joining the RCPCH Andrea was Head of the Non-communicable Disease (NCD) Department at the Ministry of Health in Chile, working on NCD policies, strengthening the national network and bringing stakeholders together. Andrea was also the Outcomes, Analytics and Benchmarking Manager at the International Consortium for Health Outcomes Measurement (ICHOM – London). At ICHOM Andrea supported the implementation of Value-Based Health Care in hospitals across the UK, Europe and South America.
She is a medical doctor with MSc degrees in Management and Organisational Innovation and Heath Systems and Global Policies, both from Queen Mary University, London, UK.
With 40 years of professional experience in Portugal and the US, António is a Medical Doctor holding specialist degrees in Internal Medicine, Nephrology and Clinical Pharmacology. He is also a Full Professor at the Faculty of Medicine, University of Lisbon (FMUL) where he directs the Centre for Evidence Based Medicine, the Institute of Preventive Medicine and Public Health, the Institute for Environmental Health and the Institute for Higher Education, having several other educational and scientific responsibilities in the FMUL.
He is a clinical researcher with special interest in the areas of secondary research (systematic reviews and meta-analyses), methodologies of translation of knowledge into practice, overutilisation of health resources, applications of artificial intelligence in medicine and research in precision medicine.
António is the Head of Cochrane Portugal and of the Scientific Council of the Institute for Evidence Based Health (ISBE).
John retired from his role as Director of Devices at the UK Medicines and Healthcare products Regulatory Agency (MHRA) in October 2019 after seven years in the role.
John was elected as Chair of the Board of Trustees for the Global Medical Devices Nomenclature in 2019.
Prior to this role, John was Chief Executive of Eucomed, the leading European medical device industry representation body, and Director General of the Association of British Healthcare Industries (ABHI). These followed extensive industry experience in sales and marketing and general management with Becton Dickinson and the BOC Group, as well as a period as chief executive of an early stage medical imaging company.
John was awarded an OBE for services to the medical device industry in the 2010 New Year’s Honours list.
He holds a first degree in Zoology from the University of Aberdeen, an MBA from the University of Warwick and he is a Fellow of the Institute of Marketing. He was made an Honorary Member of The Organisation for Professional Regulatory Affairs (TOPRA) in 2019 and received the Founders’ Award from the Regulatory Affairs Professional Society (RAPS) in 2020.
We have developed a range of engagement options, which focus on working together to achieve the vision of Person-Centred Value-Based Health Care